Abstract: Disclosed are compositions and methods related to variable lymphocyte receptors (VLRs).

Abstract: Described herein are microcapsules and emulsions prepared from low Bloom gelatin and methods of making and using thereof.

Abstract: The invention relates to an apparatus for displacing tissue within the body, wherein the apparatus includes two or more attachment members selectively displaceable with respect to each other via a driving member. The driving member preferably is rotatable and is caused to rotate by a magnetic actuator that can be activated by a magnetic field from outside the body.

Abstract: A method, system, apparatus, and computer-readable medium are described for providing distributed hot-spare storage in a redundant storage cluster. According to one method, a portion of the unutilized space on the storage cluster is utilized as a distributed hot-spare storage node. Through this mechanism, a redundant storage cluster with N storage nodes may be contracted to a redundant array with N?1 nodes. Thin provisioning and intelligent data placement may also be utilized to implement the distributed hot-spare storage node. Through repeated application of such methods and systems, the failure of any storage node or the sequential failure of multiple storage nodes within a redundant storage cluster results in the recreation of the cluster as a redundant storage array with one fewer node, but with the same redundancy.

Abstract: The present invention relates to the discovery of novel receptors for the signaling of PTH and/or fragments of PTH, and the role of cPTH in bone development. The novel PTH receptors identified are selected from the group consisting of LRP5/6, TGF?RII, BMPRII (long form and short form), ActRIIA, and ActRIIB. Specifically, the present invention provides a novel screening tool for identifying compounds that improve bone mass by affecting certain pathways that promote or downregulate bone-forming activity. This promotion of bone-forming activity could provide for treatments for bone-loss or bone density disorders and/or kidney disease. The invention further encompasses the compounds, PTH ligands, and fragments of PTH ligands described herein; pharmaceutical compositions comprising the compounds, PTH ligands, or fragments of PTH ligand; and methods of increasing bone density using the compounds, PTH ligands, or fragments of PTH ligands.

Abstract: A method, system, apparatus, and computer-readable medium are described for the background movement of data between nodes in a storage cluster. According to one method, exception tables are generated that include data identifying the areas on each node that need to be migrated to another node and the areas on each node that are to be migrated from another node. The exception tables may be generated in response to the failure of a node in the storage cluster or in other circumstances. A background resynchronization thread utilizes the contents of the exception tables to migrate data between the nodes of the cluster, thereby synchronizing the data stored on the nodes. Input/output operations directed to an area that is to be migrated from another node are redirected to the other node in accordance with a timeout period associated with the input/output operations.

Abstract: Technologies are described for implementing a migration mechanism in a data storage system containing multiple tiers of storage with each tier having different cost and performance parameters. Access statistics can be collected for each territory, or storage entity, within the storage system. Data that is accessed more frequently can be migrated toward higher performance storage tiers while data that is accessed less frequently can be migrated towards lower performance storage tiers. Each tier can be associated with a range of ILM statistics referred to as the bucket for that tier. A pivot table may be provided that relates the tiers and the buckets. Operations on the pivot table can provide counts of how many territories may be promoted or demoted between any two pairs of tiers.

Abstract: Included are embodiments for providing speech analysis. At least one embodiment of a method includes receiving audio data associated with a communication and providing the at least one phoneme in a phonetic transcript, the phonetic transcript including at least one character from a phonetic alphabet.

Abstract: Embodiments of the present invention provide systems and methods for recording media communications an exemplary method is comprised of the following steps: receiving instructions at a gateway to record an incoming call; receiving the incoming call from a calling communication device; determining whether to record the incoming call based on the received instructions; routing the incoming call to a called communication device in a customer center; responsive to the determination to record the incoming call, duplicating the media communications via the gateway; transmitting the duplicated media communications associated with the incoming call via the gateway; and recording the duplicated media communications.

Abstract: Technologies are described herein for providing networked RAID in a virtualized storage cluster. The storage capacity of a storage cluster having two or more storage nodes is organized into tiers. A portion of the available storage capacity is allocated to one tier that is organized using chained declustering. Another portion of the available storage capacity is allocated to another tier that is organized using a networked RAID configuration. The storage cluster monitors the frequency at which data in the storage cluster is accessed. Frequently used data that is stored in the network RAID-configured tier is promoted to the chained declustered-configured tier. Infrequently used data that is stored in the chained declustered-configured tier is demoted to the network RAID-configured tier. The zone size for zones stored in the chained declustered-configured tier may be different than for zones stored in the network RAID-configured tier.

Abstract: Systems and methods for capturing communication signals are provided. An exemplary method comprises the steps of: installing a first type of tapping devices to obtain 32-bit communication signals; installing a recording system that is coupled to the first type of tapping devices; receiving the 32-bit communication signals from the first type of tapping devices via the recording system; responsive to receiving the 32-bit communication signals, converting the 32-bit communication signals into an 128-bit communication format via the recording system; and recording the converted 128-bit communication signals via the recording system.

Abstract: A system, method, apparatus, and computer-readable medium are described for providing redundancy in a storage system. According to one method, maps are generated and stored that define stripe patterns for storing data on the storage nodes of a storage cluster. The maps are defined such that when a new storage node is added to the cluster, no movement of data occurs between two storage nodes that existed in the cluster prior to the addition of the new storage node during re-striping, and such that the data stored on each storage node is mirrored on another storage node. Storage nodes may also be designated as an owner or a peer for each storage zone. Input/output operations received at an owner node are fielded directly and mirrored to the peer node, while input/output operations received at a peer node are redirected to the owner node for processing.

Abstract: A process for the removal of sterols, specifically cholesterol, from a triglyceride oil, preferably a marine triglyceride oil, said process comprising contacting an oil with an absorbent, specifically TRIS YL™, clay or a mixture thereof, heating the mixture to 100° C. to 210° C., preferably 150° C. to 170° C., preferably for a time period of greater than one minute and optionally at a pressure less than 133 Pa, preferably less than 1.33 Pa.

Abstract: The present invention relates to a method of increasing the sensitivity of neoplastic cells to chemotherapeutic agents by using a virus, a method of treating proliferative disorders with a virus and chemotherapeutic agents, and a method for preventing a neoplasm from developing drug resistance to chemotherapeutic agents. The virus is preferably a reovirus.

Abstract: The present invention relates to processes utilizing ionic liquids for the dissolution of various polymers and/or copolymers, the formation of resins and blends, and the reconstitution of polymer and/or copolymer solutions, and the dissolution and blending of “functional additives” and/or various polymers and/or copolymers to form advanced composite materials.

Abstract: Disclosed are compositions, methods, and devices that generally relate to silanes and silicides and to uses thereof for hydrogen generation. Methods and devices for generating hydrogen for fuel cells and for other applications such as fuel or a supplementary fuel for internal combustion engines and reducing agents to improve catalyst efficiency are also disclosed.

Abstract: Provided herein are methods for detecting gram negative bacteria or lipopolysaccharide in a sample. Kits for detecting gram negative bacteria or lipopolysaccharide in a sample are provided.

Abstract: The invention provides for modified reovirus nucleic acid sequences and modified reovirus polypeptide sequences as well as reoviruses containing such modified nucleic acid or polypeptide sequences. The invention also provides for pharmaceutical compositions that include reoviruses having a modified sequence as well as methods of making and using such reoviruses.

Abstract: Methods for treating cell proliferative disorders by administering virus to proliferating cells having an activated Ras-pathway are disclosed. The virus is administered so that it ultimately directly contacts proliferating cells having an activated Ras-pathway. Proliferative disorders include but are not limited to neoplasms. The virus is selected from modified adenovirus, modified HSV, modified vaccinia virus and modified parapoxvirus orf virus. Also disclosed are methods for treating cell proliferative disorders by further administering an immunosuppressive agent.